TABLE 2.
Organ (row %)a | SARS-CoV-2 status | Not recovered | Recovered for transplant but not transplanted | Transplanted | Total (n) |
---|---|---|---|---|---|
Right kidney | Final test positive (F-POS) | 2 (2.9%) | 26 (37.7%)b | 41 (59.4%) | 69 |
Previously positive (P-POS)c | 8 (4.0%) | 55 (27.6%)b | 136 (68.3%) | 199 | |
All test(s) negative | 715 (4.5%) | 3345 (21.1%)b | 11 797 (74.4%) | 15 867 | |
Left kidney | Final test positive (F-POS) | 3 (4.4%) | 21 (30.4%)b | 45 (65.2%) | 69 |
Previously positive (P-POS)c | 8 (4.0%) | 50 (25.1%)b | 141 (70.9%) | 199 | |
All test(s) negative | 727 (4.5%) | 3139 (19.8%)b | 11 992 (75.6%) | 15 858 | |
Liver | Final test positive (F-POS) | 33 (47.8%) | 4 (5.8%) | 32 (46.4%) | 69 |
Previously positive (P-POS)c | 70 (36.1%) | 8 (4.1%) | 116 (59.8%) | 194 | |
All test(s) negative | 3816 (24.4%)c | 1121 (7.2%) | 10 678 (68.4%) | 15 615 | |
Heart | Final test positive (F-POS) | 60 (87.0%) | 0 (0%) | 9 (13.0%) | 69 |
Previously positive (P-POS)c | 136 (72.0%) | 0 (0%) | 53 (28.0%) | 189 | |
All test(s) negative | 9209 (65.3%)c | 47 (0.3%) | 4857 (34.4%) | 14 113 |
Abbreviation: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Sample size for other organs (lung, pancreas, liver segment, intestine, en-bloc kidneys) all <10 for positive SARS-CoV-2 status and excluded from table; dispositions of no authorization requested or obtained and recovered not for transplant excluded from analysis.
p-value <.05 for association of recovery or discard with SARS-CoV-2 status.
P-POS—former positive SARS-CoV-2 test, but final test negative.